Portfolio Entities
Portfolio Entities
About Us
About Us
Our People
Our People
Investment Strategy
Investment Strategy
Affiliates
Affiliates
Strategic Partners
Strategic Partners
Solution Partners
Solution Partners
Press Release
Press Release
Contact Us
Contact Us
Press Releases
Our Portfolio Milestones
Most recent updates from our portfolio entities
October,17 2024
Centinel Spine® Announces Record Revenue in Third Quarter 2024 as prodisc® Total Disc Replacement Growth Accelerates
Read More
September,30 2024
Synchron Announces Positive Results from U.S. COMMAND Study of Endovascular Brain-Computer Interface
Read More
September,26 2024
Over 7,500 Procedures Completed in Two Years with Centinel Spine’s prodisc® C Vivo and prodisc C SK Cervical Total Disc Replacement System Since U.S. Launch
Read More
September,24 2024
Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain
Read More
July,30 2024
Neuralink rival Synchron’s brain implant now lets people control Apple’s Vision Pro with their minds
Read More
July,12 2024
Synchron Announces Brain Computer Interface Chat Feature Powered by OpenAI
Read More
1
2
3
4
5
6
7
8
9
CONTACT US
We Welcome
Your Inquiries
Connect with our global team of experts.
505 Park Ave, New York,
NY 10022, USA
Nispetiye Cad. 39 Akat Apt. 11/3
Besiktas, Istanbul, Turkey
info@vbwatermarkholdings.com
Contact Form
Send